October 2006

 

 

 

 

 

 

 

 

 

 



 
FDA Working Group Develops MDUFMA Reauthorization Policy




Members of MassMEDIC’s FDA Working Group gathered on October 20th to begin developing a an industry policy document in advance of Congressional reauthorization of the Medical Device User Fee and Modernization Act of 2002. Chaired by Pam Weagraff of Quintiles Consulting, Inc., the group received a briefing on major MDUFMA reauthorization issues to be considered by Congress in its next session.

The user fee program for medical devices, established in 2002, is set to expire in 2007. Congress will likely review FDA performance, user fee levels, and funding levels for the Center for Devices and Radiological Health in 2007. The policy statement will be approved by MassMEDIC’s Board of Directors and distributed to all members in the coming months.